Aligos Therapeutics, Inc. · NASDAQ:ALGS

Woodline Partners LP reported a 9.80% stake in Aligos Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Woodline Partners LP reported a 9.80% stake in Aligos Therapeutics, Inc., 518,300 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
9.80%
Shares
518,300
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
Woodline Partners LP9.80%518,300

Source

View original at SEC

Related